The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1) ##STR00001## wherein I, A, X, Y and Z are specified in the description. The compounds are useful for the treatment of diseases such as mild cognitive impairment (MCI), Alzheimer's disease, Down Syndrome, Parkinson disease and Chorea Huntington.

 
Web www.patentalert.com

< Modified defensins and their use

> Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

> Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

~ 00545